Blog · Corneal conditions

Keratoconus: diagnosis and treatment simply explained

Published June 25, 2026

Keratoconus is a progressive disease of the cornea that gradually distorts it into a cone shape and blurs vision. It is a worrying diagnosis, often made in young people. Yet its management has changed profoundly: today, keratoconus can be stabilized in the vast majority of cases when it is detected early.

In this article, I explain how I make the diagnosis, how to stabilize the disease with cross-linking, how to restore vision with intracorneal ring segments and scleral lenses, and when a transplant may become necessary. I also discuss eye rubbing, the subject of my research, because it is the one factor you can act on.

Early diagnosis Anterion topography Cross-linking (CXL) Ring segments & scleral lenses DALK transplant
Diagram illustrating keratoconus: cone-shaped corneal distortion and stromal thinning
Understanding

What is keratoconus?

A corneal disease that progresses mainly in young people, but which can now be stabilized.

A cornea that changes shape

The cornea is the clear lens at the front of the eye. In keratoconus, its collagen loses strength and the cornea thins, especially in its lower part. It then gradually bulges into a cone shape, instead of keeping its regular dome.

This distortion creates irregular astigmatism that glasses cannot fully correct: vision becomes blurred, distorted, sometimes doubled. To better understand the different refractive errors, see my dedicated page.

When does it progress?

Keratoconus most often starts between the ages of 15 and 35. Progression can be significant in the first few years, and then gradual stabilization usually occurs around age 35–40. It is precisely because the disease affects young, active people that early diagnosis matters so much.

Warning signs

Certain signs should raise suspicion of keratoconus and prompt a consultation with corneal topography:

  • Gradual loss of vision, unrelated to age
  • A glasses prescription that changes often, without ever giving sharp vision
  • Astigmatism that is poorly corrected, with distorted or double vision
  • Intolerance to soft contact lenses and sensitivity to light

If you recognize several of these signs, don't wait: an early assessment genuinely changes the outlook.

The factor you can control

Eye rubbing — a modifiable cause

My research at the Hôpital National des Quinze-Vingts (Paris), with Prof. Christophe Baudouin, focuses precisely on this mechanism. Chronic eye rubbing is not just an aggravating factor: it is a central causal factor in the progression of keratoconus.

Why rubbing weakens the cornea

Repeatedly rubbing your eyes applies direct pressure to the cornea, raises the local temperature and sustains inflammation that damages the collagen. Over time, these stresses contribute to the thinning and distortion of the cornea.

Most often, a cycle sets in: an allergy or dry eye causes itching, which leads to rubbing, which in turn sustains the inflammation and itching. This cycle, sometimes reinforced by a behavioral component, lies at the heart of disease progression.

What this means for you

  • Learn to stop rubbing: instead of rubbing, gently press on your closed eyelids or apply a cool cloth
  • Treat eye allergy — see my Eye allergies page
  • Treat dry eye — see my Dry eye disease page
  • Screen children if there is a family history or an atopic background
My research

At the Quinze-Vingts, I contributed to publications describing the behavioral — sometimes addictive — dimension of eye rubbing in patients with keratoconus:

Hage A, Knoeri J, Leveziel L, et al. EYERUBBICS: The Eye Rubbing Cycle Study. J Clin Med. 2023;12(4):1529.

Hage A, Knoeri J, Leveziel L, et al. From ocular itching to eye rubbing: a review of the literature. J Fr Ophtalmol. 2023;46(2):173-184.

This work underlines the importance of patient education and of consciously stopping eye rubbing. To learn more, see my scientific publications.

At the OPHTALIFE practice

Early diagnosis — topography and tomography

Everything relies on imaging of the cornea. At the practice, I use an Anterion® (Heidelberg Engineering), a swept-source anterior segment OCT, to characterize the cornea and closely monitor how it changes over time.

Key test

Topography & tomography

In a few seconds and without contact, the Anterion provides elevation maps and full corneal pachymetry, with automatic calculation of ectasia indices.

Subclinical form

Detecting forme fruste keratoconus

Forme fruste keratoconus is an early form with no symptoms, visible only on imaging. Detecting it makes it possible to act before vision declines and to rule out risky laser surgery.

Biomechanics

Assessing corneal strength

Additional tests analyze how the cornea deforms and objectively measure its biomechanical weakness, which is useful for both diagnosis and follow-up.

Monitoring over time

Comparing to decide

Tests are repeated and compared using differential maps. It is this pattern of change that guides the decision to perform cross-linking: progressing keratoconus warrants treatment.

Good to know: the assessment is performed during your consultation, with no injection or invasive product. Results are available immediately; I go through them with you and explain the strategy best suited to your situation.

Stabilizing

Corneal cross-linking (CXL) — slowing progression

When keratoconus is progressing, the first goal is to stabilize it. Cross-linking, a technique validated since Wollensak's work in 2003, aims to halt or slow progression in the vast majority of progressive cases. I perform it myself in the operating room.

The principle

Riboflavin + UVA

The cornea is soaked with riboflavin (vitamin B2), then exposed to UVA light, which activates it.

The effect

Strengthening the collagen

The reaction creates additional bonds between collagen fibers: the cornea becomes stiffer and the distortion slows down.

The indication

Progressive keratoconus

CXL is intended for keratoconus with documented progression during follow-up, mainly at moderate stages.

What you need to understand

Cross-linking does not correct vision and does not cure keratoconus: it is a stabilizing treatment. Stabilization is reported in about 90% of patients at 5 years. Optical correction with glasses or contact lenses is therefore often still needed afterwards.

The KERALINK clinical trial (2021) confirmed its effectiveness in children and adolescents, a population in whom the disease can progress more quickly.

Recovery

With the standard (epi-off) protocol, discomfort is usual for the first 2–3 days, while the epithelium heals (5 to 7 days). Vision is blurred at first, then gradually recovers over 1 to 3 months.

I tailor the protocol to each patient and provide close follow-up, with topographic checks on the Anterion to confirm stabilization.

Restoring vision

Regaining functional vision — ring segments and lenses

Stabilizing is not always enough: vision also needs to be usable in everyday life. There are two main approaches, which are often complementary.

Intracorneal ring segments

Intracorneal ring segments are small implants inserted within the thickness of the cornea, through a tunnel created with a laser. They flatten and regularize the corneal surface, which can improve visual acuity and contact lens tolerance. Their effect is reversible: the ring segment can be removed if necessary.

They are mainly offered in moderate cases with contact lens intolerance, often in addition to cross-linking: CXL stabilizes biologically, while the ring segment regularizes optically. When implanted for keratoconus, they benefit from specific coverage by French national health insurance (Assurance Maladie) for approved indications. I perform this procedure myself at the practice.

Specialty contact lenses

When glasses are no longer enough, rigid lenses recreate a regular optical surface over the distorted cornea. Scleral lenses are a particularly attractive option: they rest on the white of the eye rather than on the cornea, which is then bathed in a reservoir of tears. Comfort and quality of vision are often excellent, even in advanced cases.

A study I contributed to showed that scleral lenses correct the complex optical aberrations of keratoconus better than conventional rigid lenses. For keratoconus, these lenses benefit from specific coverage with a prescription. I provide personalized fitting at the practice.

Advanced cases

Corneal transplant — when does it become necessary?

Thanks to cross-linking and scleral lenses, more than 90% of patients keep their own cornea. A transplant is reserved for very advanced cases.

In which situations?

A transplant is considered when the cornea has become opaque in its center, when vision remains severely impaired despite treatment, or in cases of long-standing contact lens intolerance and corneal scarring. It is a decision made after a detailed evaluation, never as a first-line option.

DALK, the reference technique

For keratoconus, the reference technique is DALK (deep anterior lamellar keratoplasty). It replaces the diseased front layers while preserving the patient's own endothelium, which eliminates the specific risk of endothelial rejection and supports good long-term graft survival. When the patient's endothelium is itself damaged, a penetrating keratoplasty (PK, full-thickness transplant) may be indicated.

Recovery

Visual recovery is gradual, over 6 to 12 months, sometimes longer. Sutures are usually removed at around one year. Residual astigmatism is common and is corrected at a later stage. Lifelong follow-up is required.

At the practice: I personally perform corneal transplants (DMEK, DALK, penetrating keratoplasty) and oversee the entire care pathway, from the indication to long-term follow-up. To learn more, see my Corneal transplant page.

Frequently asked questions

Your questions about keratoconus

Next step

Get a clear picture of your keratoconus

Early diagnosis and regular follow-up change the outlook. I see patients at the OPHTALIFE practice in Boulogne-Billancourt, next to Paris, for a complete assessment of your cornea, and together we define the strategy best suited to your situation.

Cabinet OPHTALIFE — Boulogne-Billancourt (92)
Former assistant surgeon, Hôpital des Quinze-Vingts (Paris)
Available on Doctolib
Learn more

Related pages

Condition
Keratoconus
The complete page: mechanism, stages, cross-linking, ring segments, lenses and transplant in detail.
Read →
Advanced cases
Corneal transplant
DMEK, DALK and penetrating keratoplasty: indications, techniques and recovery.
Read →
Research
Dr HAGE's publications
My research on eye rubbing, keratoconus and the ocular surface.
Read →
Bibliography

Scientific references

This article is based on key publications and on my own research. Sources can be verified via their DOI or PubMed.

  1. 1

    Hage A, Knoeri J, Leveziel L, Majoulet A, Blanc J-V, Buffault J, Labbé A, Baudouin C. EYERUBBICS: The Eye Rubbing Cycle Study. J Clin Med. 2023;12(4):1529.

  2. 2

    Hage A, Knoeri J, Leveziel L, Majoulet A, Buffault J, Labbé A, Baudouin C. From ocular itching to eye rubbing: a review of the literature. J Fr Ophtalmol. 2023;46(2):173-184.

  3. 3

    Knoeri J, Mhenni R, Friquet C, Hage A, Cuyaubère R, Borderie M, Leveziel L, Bouheraoua N, Borderie V. Comparison of optical aberrations in keratoconus with scleral versus rigid gas permeable lenses. Eur J Ophthalmol. 2024;34(2):394-398.

  4. 4

    Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620-627.

  5. 5

    Larkin DFP, Lanzetta P, Buchdahl J, et al. Effect of corneal cross-linking versus standard care on keratoconus progression in young patients: the KERALINK randomized controlled trial. Ophthalmology. 2021;128(11):1516-1526.

  6. 6

    Gomes JA, Tan D, Rapuano CJ, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34(4):359-369.

  7. 7

    Mas Tur V, MacGregor C, Jayaswal R, O'Brart D, Maycock N. A review of keratoconus: diagnosis, pathophysiology, and genetics. Surv Ophthalmol. 2017;62(6):770-783.

The content of this website is for information purposes only and is not a substitute for a medical consultation. Any treatment decision should be made together with your ophthalmologist.